Replies to post #40757 on SiNtx Technologies Inc (SINT)

[boston745]

One particular scenario im concerned with is some sort of merger with NP Aerospace. There is some synergistic value there as NP has OEM products in the medical, energy, & transportation markets in addition to armor and aerospace i believe. Obviously Sintx has products/product candidates in each of these markets and a shared resource in Mr Donald Bray who oversaw NP Aerospace subsidiaries at Morgan Ceramics before joining Sintx and setting up armor/defense/aerospace.

The way Sint stock is trading and the massive influx of shares flooding the market, this could potentially be used to create the context for shareholders of Sintx to vote for said merger; of course all shareholders have been scared away so whatever parties holding all these new shares would likely be positioned to vote for said merger. The context being created is years worth of attacking management showcasing incompetence, lack of bringing several products to market just sitting on them like Masks, to financial distress as Sintx would have little option but to accept such a merger if it cant raise sufficient funds to continue to fund its operations. Sintx funds its R&D efforts mostly primarily through the public markets. Thus keeping Sintx valuation ultra low and making it more and more difficult for Sintx to fund itself, is a great way to force such a transaction. Just look at the chart in 2022 when the trend violently departed from the general downtrend to the massive drop since despite all the good news the company has released. Me, without more information, id rather see Sintx auction its IP than merge with NP Aerospace or any other entity other than Zimmer Biomet or maybe Morgan Ceramics.

As i said previously, if this is indeed how things are going to play out, Zimmer Biomet will become a more predominate figure after said transaction. How quickly i couldnt say. Zimmer Biomet is a stakeholder in Sintx as i show with extensive evidence. So if it wanted to stop this it could by simply announcing an official collaboration/partnership/whatever with Sintx on at minimum a hip implant that has already been developed with both companies IP. If Zimmer Biomet stays silent then it wants this; Zimmer Biomet is looking to diversify its product portfolio i just do not know to what extent. Zimmer Biomet will use Sintx for its strategic benefit the way Eli Lilly used Amylin. Evidence suggests that Eli "traded" Amylin to Bristol Myers in a behind the scenes deal that lead to Eli acquiring Bristol Myers partner Imclone and Bristol acquiring Eli partner Amylin 4 years later. Thus showcasing these sorts of deals do not always have a straight path.

========================================

Sintx - Morgan Ceramics partnership & NP Aerospace Connections
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166246
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174166439

Sintx - Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353

Sintx - Zimmer connection purposefully not disclosed/removed from 2013 IPO paperwork?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294

Sintx - Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136

Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660

Zimmer Biomet Hires Si3N4 Coatings Expert for its anti-infective dvision - December 2018
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529

Zimmer Biomet pays 2.5m certain R&D payment Q2 2017, Dr Bal's investment company loans $2.5m to Sintx.Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867

Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.

One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant

========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Extra information on the status of a Si3n4 based hip implant:

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies

Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779